<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormalities of <z:chebi fb="3" ids="16335">adenosine</z:chebi> deaminase, a critical enzyme of the <z:chebi fb="0" ids="35584">purine</z:chebi> salvage pathway, have been reported in association with <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune dysfunction</z:e>, <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, and hereditary <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report data showing that erythrocyte <z:chebi fb="3" ids="16335">adenosine</z:chebi> deaminase activity is also abnormal in <z:hpo ids='HP_0004810'>congenital hypoplastic anemia</z:hpo> (the <z:e sem="disease" ids="C1260899" disease_type="Disease or Syndrome" abbrv="BDS">Diamond-Blackfan syndrome</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> deaminase activity in erythrocytes from 12 patients (mean +/- S.D., 2.20 +/- 0.77 IU per gram of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>) was substantially greater than that observed in 50 controls (0.62 +/- 0.13 IU per gram) </plain></SENT>
<SENT sid="3" pm="."><plain>Enzyme activity in affected patients was also greater than that seen in cord blood or in erythrocytes from patients with <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, Fanconi's <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo>, acquired pure red-cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>, or <z:hpo ids='HP_0005510'>transient erythroblastopenia</z:hpo> of childhood </plain></SENT>
<SENT sid="4" pm="."><plain>These observations indicate that erythrocyte <z:chebi fb="3" ids="16335">adenosine</z:chebi> deaminase activity may be a unique marker for identifying <z:hpo ids='HP_0004810'>congenital hypoplastic anemia</z:hpo> </plain></SENT>
</text></document>